What are the main financial takeaways from this filing?

The primary takeaway is BDX's release of its Q2 fiscal year 2016 financial results. The company is providing adjusted revenue and adjusted EPS figures, excluding one-time or acquisition-related items, to offer a clearer picture of ongoing operational performance and facilitate comparisons with prior periods.

Why is BDX using non-GAAP financial measures, and what does it mean for investors?

BDX uses non-GAAP measures, such as 'adjusted revenues' and 'adjusted EPS', to exclude the impact of specific events like the CareFusion acquisition costs, deferred revenue write-downs, and foreign currency fluctuations. This is intended to help investors better understand the company's core business performance by removing factors that can distort period-to-period comparisons. However, investors should always consider these non-GAAP figures alongside the official GAAP results.

What specific adjustments were made to the financial results?

The filing indicates adjustments were made to account for deferred revenue write-downs from the CareFusion acquisition, purchase accounting adjustments, acquisition-related financing, transaction, integration, and restructuring costs, litigation charges, and the dilutive impact of shares from the CareFusion acquisition. Foreign currency translation effects are also excluded from reported growth rates.

What is the significance of the CareFusion acquisition mentioned in the filing?

The CareFusion acquisition, completed in March 2015, has a significant impact on the financial reporting for the periods discussed. The company is making specific adjustments to its revenue and EPS figures to account for costs and accounting treatments related to this acquisition, aiming to provide a 'comparable' view of performance as if the acquisition had occurred earlier or to isolate its impact.

BDX 8-K: Earnings & Results

Summary

This Form 8-K filing by BECTON DICKINSON & CO (BDX) on May 5, 2016, primarily announces their financial results for the second fiscal quarter ending March 31, 2016, via a press release furnished as Exhibit 99.1. A key aspect of the filing is the company's use of non-GAAP (Generally Accepted Accounting Principles) financial measures to provide a clearer view of underlying operational performance. Investors should note the adjustments made to revenue and earnings per share (EPS) calculations. These adjustments exclude items such as acquisition-related costs (specifically mentioning the CareFusion acquisition), deferred revenue write-downs, foreign currency translation effects, and other integration or restructuring charges. BDX emphasizes that these non-GAAP measures are intended to enhance comparability to prior periods and facilitate a better understanding of the company's core business performance, but they are presented as supplemental to, and not a substitute for, GAAP results.

Key Highlights

1BDX reported financial results for its second fiscal quarter ending March 31, 2016.
2The company is utilizing non-GAAP financial measures to present a more insightful view of its performance.
3Key non-GAAP adjustments include the impact of the CareFusion acquisition and deferred revenue write-downs.
4Adjusted revenue and adjusted EPS figures are provided to allow for better period-over-period comparability.
5The filing highlights the exclusion of foreign currency translation effects from reported growth rates.
6Management believes these non-GAAP measures offer a better understanding of underlying operational results and are used for performance evaluation and planning.
7The press release containing these financial results is furnished as Exhibit 99.1 to the 8-K filing.

BECTON DICKINSON & CO 8-K Report, Financial Results (May 5, 2016)

Summary

Key Highlights

Frequently Asked Questions